Akebia Therapeutics, Inc. Financial Ratios — AKBA Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-51.66	-136.35	-77.27	-37.86	-54.27	-119.82	-175.37	-237.83	- -	- -	- -
Return on Assets (%)	- -	-71.35	-50.85	-47.82	-61.26	-22.17	-21.1	-31.64	-54.38	-48.07	-21.28	-17.37	-30.02	-1.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	100	100	96.26	56.62	-0.62	28.81	70.74	61.9	60.56	83.29
EBITDA Margin (%)	- -	- -	- -	- -	-8,870.62	-41.97	-84.6	-73.92	-116.46	-107.03	-9.28	-4.34	-8.06	10.49
Operating Margin (%)	- -	- -	- -	- -	-8,889.9	-42.31	-85.76	-85.46	-128.23	-124.97	-22.17	-23.67	-31.47	9.95
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	97.23
Pretax Margin (%)	- -	- -	- -	- -	-8,843.45	-40.65	-82.76	-85.46	-130.61	-133.25	-32.22	-26.68	-43.33	-1.58
Profit Margin (%)	- -	- -	- -	- -	-8,843.45	-40.65	-69.12	-83.48	-130.61	-133.25	-32.22	-26.68	-43.33	-2.26
Net Income to Common Margin (%)	- -	- -	- -	- -	-8,843.45	-40.65	-69.12	-83.48	-130.61	-133.25	-32.22	-26.68	-43.33	-2.26
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-51.66	-136.35	-77.27	-37.86	-54.27	-119.82	-175.37	-237.83	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	15	108	126	136	100	48	48	52
ST Debt	- -	- -	- -	- -	- -	- -	15	5	5	102	37	22	5	4
LT Debt	- -	- -	- -	- -	- -	- -	- -	103	121	34	63	26	42	48
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	-0.09	-0.44	-0.37	-0.6	-3.68	-5.7	-3.69	2.09
Net Debt/EBITDA	0.19	1.33	0.87	0.81	1.38	0.92	0.51	0.29	0.39	0.23	0.9	0.98	1.02	-5.51
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	-0.08	-0.38	-0.33	-0.51	-1.54	-1.04	-0.94	2.2
Net Debt/EBIT	0.19	1.33	0.86	0.81	1.37	0.91	0.5	0.25	0.35	0.2	0.38	0.18	0.26	-5.81
EBITDA to Interest Expense	- -	-22.64	- -	- -	- -	- -	- -	- -	-38.68	-11.36	-1.73	-1.4	-0.71	1.02
EBITDA-CapEx/Interest Expense	- -	-22.67	- -	- -	- -	- -	- -	- -	-38.72	-11.37	-1.74	-1.4	-0.71	0.69
EBIT to Interest Expense	- -	-22.65	- -	- -	- -	- -	- -	- -	-42.59	-13.27	-4.13	-7.64	-2.77	0.97
Interest Expense	- -	1	- -	- -	- -	- -	- -	- -	9	20	16	6	18	24
Common Equity/Total Assets	-2,655.59	-366.57	93.77	91.65	22.69	33.65	63.81	51.19	38.44	13.98	1.47	-12.65	-22.29	8.66
Long-Term Debt/Equity (%)	- -	0.03	- -	- -	- -	- -	- -	26.18	48.87	45.54	1,205.33	- -	- -	147.96
Long-Term Debt/Capital (%)	- -	0.03	- -	- -	- -	- -	- -	20.54	32.36	16.04	60.03	149	-2,733.98	57.16
Long-Term Debt/Total Assets (%)	- -	0.02	- -	- -	- -	- -	- -	13.4	18.78	6.37	17.7	10.81	19.14	12.81
Total Debt/Equity (%)	- -	0.04	- -	- -	- -	- -	2.36	27.44	51	183.83	1,907.9	-157.34	-96.86	158.84
Total Debt/Capital (%)	- -	0.04	- -	- -	- -	- -	2.3	21.53	33.77	64.77	95.02	274.4	-3,083.5	61.37
Total Debt/Total Assets (%)	- -	0.03	- -	- -	- -	- -	1.51	14.05	19.61	25.7	28.02	19.91	21.59	13.76
Net Debt to Equity	61.25	-68.98	-31.5	-38	-275.01	-57.24	-14.1	-18.15	-53.44	-70.61	-466.31	26.95	26.79	-418.87
Net Debt/Capital (%)	37.98	-222.1	-45.98	-61.29	157.14	-133.84	-16.41	-20.15	-91.13	-86.72	-167.65	32.46	24.67	136
EBITDA	-9	-16	-38	-61	-136	-76	-176	-248	-343	-227	-27	-8	-13	25
EBITDA-CapEx	-9	-16	-38	-62	-139	-78	-177	-254	-343	-227	-27	-8	-13	17
Operating Income (Loss)	-9	-16	-38	-62	-136	-77	-178	-286	-378	-265	-65	-46	-50	23

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.33	8.34	15.82	11.67	2.28	2.25	1.21	0.71	1.44	0.57	0.7	0.43	0.64	1.13
Current Ratio	0.46	8.57	16.05	11.88	2.59	2.54	1.76	1.49	1.98	1.04	1.43	1.18	1.41	1.55
Quick Ratio	0.35	8.38	15.83	11.67	2.57	2.49	1.27	0.9	1.58	0.77	1.01	0.82	1.07	1.42
CFO/Avg Current Liab	- -	-2.57	-5.1	-5.59	0.92	-0.44	-0.48	-1.09	-0.56	-1.13	-0.37	-0.2	-0.45	0.56
Common Equity/Total Assets	-2,655.59	-366.57	93.77	91.65	22.69	33.65	63.81	51.19	38.44	13.98	1.47	-12.65	-22.29	8.66
Long-Term Debt/Equity (%)	- -	0.03	- -	- -	- -	- -	- -	26.18	48.87	45.54	1,205.33	- -	- -	147.96
Long-Term Debt/Capital (%)	- -	0.03	- -	- -	- -	- -	- -	20.54	32.36	16.04	60.03	149	-2,733.98	57.16
Long-Term Debt/Total Assets (%)	- -	0.02	- -	- -	- -	- -	- -	13.4	18.78	6.37	17.7	10.81	19.14	12.81
Total Debt/Equity (%)	- -	0.04	- -	- -	- -	- -	2.36	27.44	51	183.83	1,907.9	-157.34	-96.86	158.84
Total Debt/Capital (%)	- -	0.04	- -	- -	- -	- -	2.3	21.53	33.77	64.77	95.02	274.4	-3,083.5	61.37
Total Debt/Total Assets (%)	- -	0.03	- -	- -	- -	- -	1.51	14.05	19.61	25.7	28.02	19.91	21.59	13.76
CFO/Total Liabilities	-146.47	-289.82	-397.33	-438.85	24.95	-23.24	-27.04	-68.39	-27.84	-55.56	-20.85	-8.59	-15.07	19.77
CFO/CapEx	- -	-596.42	-120.01	-126.59	21.75	-34.62	-60.71	-38.68	-348.23	-4,287.54	-641.7	- -	-1,232.09	8.4
Altman's Z-Score	-51.15	-5.63	19.29	17.99	-1.11	0.85	-0.32	-2.54	-4.72	-6.92	-8.86	-14.39	-13.38	-5.35

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	0.09	5.33	8.17	12.07	8.97	5.4	6.37	4.89	4.35	5.8
Days Sales Outstanding	- -	- -	- -	- -	4,021.3	68.52	44.7	30.25	40.7	67.63	57.32	74.62	83.92	62.89
Inventory Turnover	- -	- -	- -	- -	- -	- -	0.14	1.26	3.34	3.09	2.94	3.98	3.96	2.48
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	2,684.05	289.56	109.18	118.27	124.12	91.7	92.25	147.31
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	4.9	3.6	5.99	3.37	2.73	4.18	4.27	2.14
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	74.48	101.52	60.94	108.24	133.58	87.29	85.38	170.92
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	2,654.27	218.3	88.94	77.67	47.86	79.03	90.79	39.29
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-2,639.35	-259.31	-68.48	-50.64	-66.8	-17.09	-8.33	-84.42
Inventories	- -	- -	- -	- -	- -	- -	114	116	61	37	22	16	16	16
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	4	12	13
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14	11	4	3
Other Inventory	- -	- -	- -	- -	- -	- -	114	116	61	37	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	237	396	402	708	646	769	415	400	106	241	427	427
- Cash & Cash Equivalents	2	21	33	50	187	70	105	147	229	150	90	43	52	185
+ Preferred Equity and Hybrid Capital	57	158	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	15	108	126	136	100	48	48	52
Enterprise Value	55	125	128	258	142	390	340	730	272	386	116	246	423	294
Total Capital	-3	31	104	131	68	123	651	503	374	210	105	18	-2	84
Total Debt/Capital (%)	- -	0.04	- -	- -	- -	- -	2.3	21.53	33.77	64.77	95.02	274.4	-3,083.5	61.37
Total Debt / EV	- -	- -	- -	- -	- -	- -	0.04	0.15	0.46	0.35	0.86	0.2	0.11	0.18
EV/Sales	- -	- -	- -	- -	92.28	2.15	1.64	2.18	0.92	1.83	0.4	1.27	2.64	1.25
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.88
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.52
EV/Cash Flow to Firm	- -	- -	- -	- -	2.45	- -	- -	- -	- -	- -	- -	- -	- -	2.86
EV/Free Cash Flow to Firm	- -	- -	- -	- -	2.34	- -	- -	- -	- -	- -	- -	- -	- -	2.66
Diluted Market Cap	- -	- -	179	342	393	647	646	748	388	375	105	232	401	414
Diluted Enterprise Value	55	137	147	292	205	577	557	709	285	361	115	238	397	281
EV per Share	2.87	6.17	6.29	8.4	3.67	8.2	2.91	6	1.84	2.18	0.63	1.27	1.88	1.11
TTM Sales	- -	- -	- -	- -	2	181	208	335	295	212	292	195	160	236
TTM EBITDA	-9	-16	-38	-61	-136	-76	-176	-248	-343	-227	-27	-8	-13	25
TTM Operating Income	-9	-16	-38	-62	-136	-77	-178	-286	-378	-265	-65	-46	-50	23
TTM Cash Flow to Firm	-7	-11	-27	-52	58	-56	-97	-257	-102	-233	-57	-17	-22	103
TTM Free Cash Flow to Firm	-7	-11	-27	-52	61	-55	-96	-251	-101	-233	-57	-17	-22	111

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-6.58	-6.58	6.48	-11.86	-6.74	-2.98	-3.52	-1.48	-1.44	-9.94	-9.87	5.44
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.52
Enterprise Value	55	125	128	258	142	390	340	730	272	386	116	246	423	294
Low Price	- -	- -	8.6	5.91	7	8.58	5.2	2.99	2.09	2.2	0.24	0.49	0.8	1.45
EV/Sales	- -	- -	- -	- -	92.28	2.15	1.64	2.18	0.92	1.83	0.4	1.27	2.64	1.25
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.88
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-8.51	-4.2	-2.36	-8.04	-8.27	-2.28	-2.68	-1.84	-1.57	-3.64	-4.49	-123.11
Price/Earnings High	- -	- -	-12.9	-6.19	-3.54	-11.96	-12.91	-3.94	-4.93	-3.02	-5.68	-6.64	-7.54	-196.3
Price/Earnings Low	- -	- -	-3.58	-2.58	-1.94	-5.07	-4.23	-1.27	-0.75	-1.29	-0.47	-1.77	-2.43	-69.76
Price/Book Value	- -	- -	2.28	3.02	5.9	5.78	1.02	1.95	1.67	5.41	20.31	-7.89	-8.69	13.1
Price/Book Value Average	- -	- -	4.01	2.25	4.81	5.29	1.87	1.66	4.45	7.49	28.55	-6.42	-6.75	20.83
Price/Book Value High	- -	- -	6.07	3.32	7.22	7.87	2.92	2.87	8.2	12.29	103.16	-11.71	-11.34	33.21
Price/Book Value Low	- -	- -	1.68	1.38	3.97	3.33	0.96	0.92	1.25	5.26	8.49	-3.12	-3.66	11.8
Price/Tangible Book Value	- -	- -	2.28	3.02	5.9	5.78	2.56	15.86	8.57	-4.29	-0.84	-1.92	-3.95	-16.17
Price/Tangible Book Value Average	- -	- -	4.01	2.25	4.81	5.29	4.7	13.5	22.77	-5.95	-1.19	-1.56	-3.07	-25.69
Price/Tangible Book Value High	- -	- -	6.07	3.32	7.22	7.87	7.34	23.34	41.95	-9.77	-4.29	-2.85	-5.15	-40.97
Price/Tangible Book Value Low	- -	- -	1.68	1.38	3.97	3.33	2.41	7.5	6.39	-4.18	-0.35	-0.76	-1.66	-14.56
Price/Sales	- -	- -	- -	- -	255.79	3.57	3.11	2.23	1.32	1.77	0.36	1.19	2.5	1.75
Price/Sales Average	- -	- -	- -	- -	208.64	3.27	5.72	1.9	3.5	2.45	0.51	0.97	1.94	2.79
Price/Sales High	- -	- -	- -	- -	313.04	4.86	8.92	3.29	6.44	4.03	1.83	1.77	3.27	4.44
Price/Sales Low	- -	- -	- -	- -	172	2.06	2.93	1.06	0.98	1.72	0.15	0.47	1.05	1.58
Price/Cash Flow	- -	- -	-6.53	-6.53	6.78	-11.52	-6.63	-2.91	-3.51	-1.48	-1.44	-9.94	-9.86	6.09
Price/Cash Flow Average	- -	- -	-11.47	-4.86	5.53	-10.55	-12.18	-2.47	-9.33	-2.05	-2.03	-8.09	-7.66	9.68
Price/Cash Flow High	- -	- -	-17.38	-7.17	8.3	-15.69	-19.01	-4.28	-17.2	-3.37	-7.32	-14.75	-12.87	15.43
Price/Cash Flow Low	- -	- -	-4.82	-2.98	4.56	-6.65	-6.23	-1.38	-2.62	-1.44	-0.6	-3.93	-4.15	5.48
Price/Free Cash Flow Average	- -	- -	-11.57	-4.9	5.29	-10.86	-12.39	-2.54	-9.36	-2.05	-2.03	-8.09	-7.66	8.65
Price/Free Cash Flow High	- -	- -	-17.52	-7.23	7.93	-16.15	-19.33	-4.39	-17.25	-3.37	-7.33	-14.75	-12.88	13.79
Price/Free Cash Flow Low	- -	- -	-4.86	-3.01	4.36	-6.84	-6.34	-1.41	-2.63	-1.44	-0.6	-3.93	-4.15	4.9
EV/Sales Average	- -	- -	- -	- -	91.57	3.19	5.29	1.84	3.39	2.55	0.54	1.04	2.05	2.31
EV/Sales High	- -	- -	- -	- -	198.46	4.93	8.49	3.26	6.54	4.23	1.88	1.87	3.45	4.02
EV/Sales Low	- -	- -	- -	- -	54.06	1.87	2.49	0.97	0.7	1.77	0.18	0.52	1.1	1.07
EV/EBITDA Average	-6.48	-8.58	-10.14	-4	-1.03	-7.6	-6.25	-2.48	-2.91	-2.39	-5.84	-23.87	-25.38	22.05
EV/EBITDA High	-6.48	-8.58	-15.8	-6.28	-2.24	-11.75	-10.04	-4.41	-5.62	-3.96	-20.22	-43	-42.87	38.35
EV/EBITDA Low	-6.48	-8.58	-3.76	-2.14	-0.61	-4.45	-2.95	-1.31	-0.6	-1.66	-1.98	-11.9	-13.61	10.17
EV/EBIT Average	-6.48	-8.57	-10.13	-3.99	-1.03	-7.54	-6.16	-2.15	-2.65	-2.04	-2.45	-4.38	-6.5	23.24
EV/EBIT High	-6.48	-8.57	-15.78	-6.27	-2.23	-11.66	-9.9	-3.82	-5.1	-3.39	-8.46	-7.88	-10.98	40.42
EV/EBIT Low	-6.48	-8.57	-3.75	-2.14	-0.61	-4.41	-2.91	-1.13	-0.55	-1.42	-0.83	-2.18	-3.48	10.72
Last Price	- -	- -	11.64	12.92	10.41	14.87	5.53	6.32	2.8	2.26	0.58	1.24	1.9	1.61
High Price	- -	- -	31	14.2	12.74	20.25	15.86	9.3	13.71	5.14	2.93	1.84	2.48	4.08
Enterprise Value Average	55	137	384	246	141	578	1,098	615	999	540	159	202	328	546
Enterprise Value High	55	137	599	386	305	894	1,764	1,092	1,928	896	549	363	553	950
Enterprise Value Low	55	137	142	131	83	338	518	325	207	376	54	101	176	252

Shares Outstanding	19	20	20	31	39	48	117	122	148	177	184	195	225	265
Diluted Weighted Avg Shares	10	19	15	26	38	44	117	118	138	166	183	187	211	257
Basic Weighted Avg Shares	10	19	15	26	38	44	117	118	138	166	183	187	211	257
Revenue per Share	- -	- -	- -	- -	0.04	4.17	1.78	2.83	2.13	1.28	1.6	1.04	0.76	0.92
EBITDA per Share	-0.84	-0.83	-2.46	-2.32	-3.61	-1.75	-1.5	-2.09	-2.48	-1.37	-0.15	-0.05	-0.06	0.1
Operating Income per Share	-0.84	-0.83	-2.46	-2.32	-3.62	-1.76	-1.52	-2.42	-2.73	-1.59	-0.35	-0.25	-0.24	0.09
Basic EPS, GAAP	-0.81	-0.68	-2.4	-2.29	-3.6	-1.69	-1.23	-2.36	-2.78	-1.7	-0.52	-0.28	-0.33	-0.02
Basic EPS from Cont Ops	-0.81	-0.68	-2.4	-2.29	-3.6	-1.69	-1.23	-2.36	-2.78	-1.7	-0.52	-0.28	-0.33	-0.02
Diluted EPS, GAAP	-0.81	-0.68	-2.4	-2.29	-3.6	-1.69	-1.23	-2.36	-2.78	-1.7	-0.52	-0.28	-0.33	-0.02
Diluted EPS from Cont Ops	-0.81	-0.68	-2.4	-2.29	-3.6	-1.69	-1.23	-2.36	-2.78	-1.7	-0.52	-0.28	-0.33	-0.02
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.71	-0.59	-1.78	-1.98	1.54	-1.29	-0.83	-2.17	-0.8	-1.52	-0.4	-0.12	-0.19	0.26
Free Cash Flow per Basic Share	-0.71	-0.59	-1.8	-2	1.46	-1.33	-0.85	-2.23	-0.8	-1.52	-0.4	-0.12	-0.19	0.23
Cash & Equivalents per Share	0.09	1.6	5.35	4.52	6.74	6.67	2.75	1.21	1.81	0.85	0.49	0.22	0.23	0.7
Book Value per Share	-3.09	-6.26	5.11	4.27	1.76	2.57	5.44	3.24	1.67	0.42	0.03	-0.16	-0.22	0.12
Tangible Book Value per Share	-3.09	-6.26	5.11	4.27	1.76	2.57	2.16	0.4	0.33	-0.53	-0.68	-0.65	-0.48	-0.1

Akebia Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)